Issue Date: April 18, 2016
Amyris to revise artemisinin route
Industrial biotechnology firm Amyris will work to reduce the cost of making the malaria treatment artemisinin via fermentation with help from a $5 million investment from the Bill & Melinda Gates Foundation. The company first developed its biotech route to the drug in 2005. The product is also derived from the herb sweet wormwood, but supplies are subject to shortages.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society